Laboratory Net Working Capital from 2010 to 2024

LH Stock  USD 200.08  1.24  0.62%   
Laboratory's Net Working Capital is increasing with slightly volatile movements from year to year. Net Working Capital is predicted to flatten to about 513.2 M. For the period between 2010 and 2024, Laboratory, Net Working Capital quarterly trend regression had mean deviation of  463,905,244 and range of 2.2 B. View All Fundamentals
 
Net Working Capital  
First Reported
2010-12-31
Previous Quarter
540.2 M
Current Value
513.2 M
Quarterly Volatility
633.3 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Laboratory financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Laboratory main balance sheet or income statement drivers, such as Interest Expense of 209.6 M, Total Revenue of 12.8 B or Gross Profit of 1.9 B, as well as many exotic indicators such as Price To Sales Ratio of 1.6, Dividend Yield of 0.0122 or PTB Ratio of 3.27. Laboratory financial statements analysis is a perfect complement when working with Laboratory Valuation or Volatility modules.
  
This module can also supplement Laboratory's financial leverage analysis and stock options assessment as well as various Laboratory Technical models . Check out the analysis of Laboratory Correlation against competitors.

Latest Laboratory's Net Working Capital Growth Pattern

Below is the plot of the Net Working Capital of Laboratory of over the last few years. It is Laboratory's Net Working Capital historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Laboratory's overall financial position and show how it may be relating to other accounts over time.
Net Working Capital10 Years Trend
Slightly volatile
   Net Working Capital   
       Timeline  

Laboratory Net Working Capital Regression Statistics

Arithmetic Mean904,552,667
Geometric Mean767,114,201
Coefficient Of Variation70.02
Mean Deviation463,905,244
Median636,500,000
Standard Deviation633,330,773
Sample Variance401107.9T
Range2.2B
R-Value0.37
Mean Square Error372738.8T
R-Squared0.14
Significance0.17
Slope52,437,250
Total Sum of Squares5615510.1T

Laboratory Net Working Capital History

2024513.2 M
2023540.2 M
20221.5 B
20212.5 B
2020B
2019325.4 M
2018956.5 M

About Laboratory Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Laboratory income statement, its balance sheet, and the statement of cash flows. Laboratory investors use historical funamental indicators, such as Laboratory's Net Working Capital, to determine how well the company is positioned to perform in the future. Although Laboratory investors may use each financial statement separately, they are all related. The changes in Laboratory's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Laboratory's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Laboratory Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Laboratory. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Net Working Capital540.2 M513.2 M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Laboratory offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Laboratory's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Laboratory Of Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Laboratory Of Stock:
Check out the analysis of Laboratory Correlation against competitors.
Note that the Laboratory information on this page should be used as a complementary analysis to other Laboratory's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.

Complementary Tools for Laboratory Stock analysis

When running Laboratory's price analysis, check to measure Laboratory's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Laboratory is operating at the current time. Most of Laboratory's value examination focuses on studying past and present price action to predict the probability of Laboratory's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Laboratory's price. Additionally, you may evaluate how the addition of Laboratory to your portfolios can decrease your overall portfolio volatility.
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Is Laboratory's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Laboratory. If investors know Laboratory will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Laboratory listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.123
Dividend Share
2.88
Earnings Share
4.67
Revenue Per Share
142.986
Quarterly Revenue Growth
0.046
The market value of Laboratory is measured differently than its book value, which is the value of Laboratory that is recorded on the company's balance sheet. Investors also form their own opinion of Laboratory's value that differs from its market value or its book value, called intrinsic value, which is Laboratory's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Laboratory's market value can be influenced by many factors that don't directly affect Laboratory's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Laboratory's value and its price as these two are different measures arrived at by different means. Investors typically determine if Laboratory is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Laboratory's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.